Lexicon Pharmaceuticals (LXRX) Q2 2024 Earnings

2MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.22
-0.2
-0.19
-0.17

Details

Expected EPS
-0.18
Actual EPS
-0.2
Surprise EPS
-0.02
Surprise Percent
+11.11%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.2 per share for Q2 2024.

0 Comments

Share your thoughts